UCSD and the Department of Veterans Affairs Collaboration CARLSBAD, CA, UNITED STATES, December 31, 2025 /EINPresswire.com/ — AVACEN Medical announced today that Dr. Francisco Cidral, ND, PhD’s ...

Fibromyalgia is a chronic condition that causes widespread pain all over the body, fatigue and poor sleep, and it often also causes problems with mood, memory and concentration. It affects about 2% of ...

A noninvasive, home-based brain treatment with transcranial direct current stimulation (tDCS) can reduce pain severity, improve pain-related disability, and enhance endogenous pain modulation in women ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted clearance to Multi Radiance Medical’s FibroLux therapy laser for the treatment of pain in ...

SAN FRANCISCO--(BUSINESS WIRE)--Swing Therapeutics, a digital therapeutics company developing evidence-backed treatments for autoimmune and chronic pain conditions, today announced the presentation of ...

ST. CLOUD, Minn. -- Imagine one of the worst pains you've ever felt in your life. Now imagine someone telling you it's all in your head. "It was extremely frustrating," said Karen Linnell, who was ...

“TNX-102 SL, Cyclobenzaprine HCl Sublingual Tablets, Demonstrates Pain Reduction and Favorable Tolerability in Participants With Fibromyalgia” “Sublingual Cyclobenzaprine (TNX-102 SL) for Fibromyalgia ...

CHATHAM, NEW JERSEY / ACCESS Newswire / March 31, 2025 / This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp.

Patients living with fibromyalgia (FM) -- a disease that predominantly affects women and is characterized by chronic pain, fatigue and brain fog -- often find limited treatment options and a scarcity ...

TNX-102 SL is the first new fibromyalgia treatment approved in over 15 years, joining three other treatments. Phase 3 trials showed significant pain reduction and good tolerance, with improvements in ...

In August 2025, the US Food and Drug Administration (FDA) approved Tonmya ® (cyclobenzaprine hydrochloride sublingual tablets; Tonix Pharmaceuticals) for the treatment of fibromyalgia in adults. Study ...

CHATHAM, N.J., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biotechnology company, today announced that the U.S. Food and Drug ...